Hem › Njurcancer (renalcelskarcinom) › North Carolina › Durham
Kliniska studier för Njurcancer (renalcelskarcinom) i Durham, NC
12 studier för Njurcancer (renalcelskarcinom) söker deltagare vid platser i och runt Durham (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
RekryterarFas 1/2
- Duke Cancer Institute ( Site 5015), Durham
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekryterarObservationsstudieFriska volontärer välkomna
- Durham VA Medical Center, Durham
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekryterarFas 1
- Exelixis Clinical Site #12, Durham
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekryterarFas 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi bort
DESTINY-PANTUMOUR04
RekryterarObservationsstudie
- Research Site, Durham
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
RekryterarFas 2
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi bort
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RekryterarObservationsstudie
- UNC- Chapel Hill, Chapel Hill · 10 mi bort
A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
RekryterarFas 2
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi bort
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
RekryterarFas 3
- Duke University Medical Center, Durham
- Duke Cancer Center Southpoint, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi bort
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
RekryterarFas 1
- Xencor Investigative Site, Durham
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
RekryterarFas 1
- Duke Cancer Center /ID# 251975, Durham
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
RekryterarFas 1/2
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi bort
Njurcancer (renalcelskarcinom)-studier i andra städer
- Houston, TX35 studier
- New York City, NY27 studier
- Dallas, TX23 studier
- Nashville, TN23 studier
- St. Louis, MO23 studier
- Los Angeles, CA20 studier
- Boston, MA16 studier
- Baldwin Park, CA16 studier
- Philadelphia, PA15 studier
- Pittsburgh, PA15 studier
- Queens, NY15 studier
- Jacksonville, FL14 studier
Andra studier i Durham
- Bröstcancer64 studier
- Cancer (alla typer)58 studier
- Icke-småcellig lungcancer39 studier
- Multipelt myelom37 studier
- Akut myeloid leukemi33 studier
- Metastaserande cancer33 studier
- Prostatacancer32 studier
- Lungcancer32 studier
- Kolorektal cancer28 studier
- Äggstockscancer27 studier
- Kronisk lymfatisk leukemi27 studier
- Hjärtsvikt26 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.